Mechanism of action of topoisomerase II-targeted antineoplastic drugs.

[1]  N. Osheroff,et al.  Drug features that contribute to the activity of quinolones against mammalian topoisomerase II and cultured cells: correlation between enhancement of enzyme-mediated DNA cleavage in vitro and cytotoxic potential , 1993, Antimicrobial Agents and Chemotherapy.

[2]  N. Osheroff,et al.  When good enzymes go bad: conversion of topoisomerase II to a cellular toxin by antineoplastic drugs. , 1993, Chemical research in toxicology.

[3]  J. Wang,et al.  On the simultaneous binding of eukaryotic DNA topoisomerase II to a pair of double-stranded DNA helices. , 1993, The Journal of biological chemistry.

[4]  J. Roca,et al.  The capture of a DNA double helix by an ATP-dependent protein clamp: A key step in DNA transport by type II DNA topoisomerases , 1992, Cell.

[5]  N. Osheroff,et al.  Cytotoxicity of quinolones toward eukaryotic cells. Identification of topoisomerase II as the primary cellular target for the quinolone CP-115,953 in yeast. , 1992, The Journal of biological chemistry.

[6]  T. Ashizawa,et al.  Antitumor quinolones with mammalian topoisomerase II mediated DNA cleavage activity. , 1992, Cancer research.

[7]  N. Osheroff,et al.  Effects of novel fluoroquinolones on the catalytic activities of eukaryotic topoisomerase II: Influence of the C-8 fluorine group , 1992, Antimicrobial Agents and Chemotherapy.

[8]  J. Wang,et al.  Two independent amsacrine-resistant human myeloid leukemia cell lines share an identical point mutation in the 170 kDa form of human topoisomerase II. , 1992, Journal of molecular biology.

[9]  N. Osheroff,et al.  A role for the passage helix in the DNA cleavage reaction of eukaryotic topoisomerase II. A two-site model for enzyme-mediated DNA cleavage. , 1992, The Journal of biological chemistry.

[10]  N. Wideburg,et al.  Induction of calf thymus topoisomerase II-mediated DNA breakage by the antibacterial isothiazoloquinolones A-65281 and A-65282 , 1992, Antimicrobial Agents and Chemotherapy.

[11]  A. Harris,et al.  Relationship between topoisomerase II level and chemosensitivity in human tumor cell lines. , 1991, Cancer research.

[12]  D. Sullivan,et al.  Attenuated topoisomerase II content directly correlates with a low level of drug resistance in a Chinese hamster ovary cell line. , 1991, Cancer research.

[13]  J. Wang,et al.  Proteolysis patterns of epitopically labeled yeast DNA topoisomerase II suggest an allosteric transition in the enzyme induced by ATP binding. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  K. Kohn,et al.  Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposide. , 1991, Nucleic acids research.

[15]  D. Suttle,et al.  Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[16]  K. Deisseroth,et al.  Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II. , 1991, Cancer research.

[17]  W. T. Beck,et al.  Decreased DNA topoisomerase II in daunorubicin-resistant Ehrlich ascites tumor cells. , 1991, Cancer research.

[18]  N. Osheroff,et al.  Effects of quinolone derivatives on eukaryotic topoisomerase II. A novel mechanism for enhancement of enzyme-mediated DNA cleavage. , 1991, The Journal of biological chemistry.

[19]  N. Osheroff,et al.  Catalytic function of DNA topoisomerase II , 1991, BioEssays : news and reviews in molecular, cellular and developmental biology.

[20]  K. Lund,et al.  Studies of the topoisomerase II-mediated cleavage and religation reactions by use of a suicidal double-stranded DNA substrate. , 1991, The Journal of biological chemistry.

[21]  K. Deisseroth,et al.  Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actions. , 1991, Biochemistry.

[22]  J. Wang,et al.  DNA topoisomerases: why so many? , 1991, The Journal of biological chemistry.

[23]  N. Osheroff,et al.  Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase II. , 1991, Biochemistry.

[24]  K. Akahane,et al.  Significance of the methyl group on the oxazine ring of ofloxacin derivatives in the inhibition of bacterial and mammalian type II topoisomerases , 1991, Antimicrobial Agents and Chemotherapy.

[25]  A. Maxwell,et al.  Novel quinolone resistance mutations of the Escherichia coli DNA gyrase A protein: enzymatic analysis of the mutant proteins , 1991, Antimicrobial Agents and Chemotherapy.

[26]  J. Griffith,et al.  Drosophila topoisomerase II-DNA interactions are affected by DNA structure. , 1991, Journal of molecular biology.

[27]  R. J. Reece,et al.  DNA gyrase: structure and function. , 1991, Critical reviews in biochemistry and molecular biology.

[28]  N. Osheroff,et al.  Eukaryotic topoisomerases recognize nucleic acid topology by preferentially interacting with DNA crossovers. , 1990, The EMBO journal.

[29]  K. Kohn,et al.  Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin. , 1990, Nucleic acids research.

[30]  L. Liu,et al.  Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. , 1990, Cancer research.

[31]  N. Osheroff,et al.  Uncoupling the DNA cleavage and religation activities of topoisomerase II with a single-stranded nucleic acid substrate: evidence for an active enzyme-cleaved DNA intermediate. , 1990, Biochemistry.

[32]  N. Moreau,et al.  Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II , 1990, Antimicrobial Agents and Chemotherapy.

[33]  B. Thomsen,et al.  Stimulation of topoisomerase II mediated DNA cleavage at specific sequence elements by the 2-nitroimidazole Ro 15-0216. , 1990, Biochemistry.

[34]  K. Lund,et al.  Characterization of the interaction between topoisomerase II and DNA by transcriptional footprinting. , 1990, Journal of molecular biology.

[35]  P. Caron,et al.  The role of DNA topoisomerases in recombination and genome stability: A double-edged sword? , 1990, Cell.

[36]  S. Nakamura,et al.  Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli , 1990, Antimicrobial Agents and Chemotherapy.

[37]  C. Holm,et al.  Segregation of recombined chromosomes in meiosis I requires DNA topoisomerase II , 1990, Cell.

[38]  N. Osheroff,et al.  Stabilization of the topoisomerase II-DNA cleavage complex by antineoplastic drugs: inhibition of enzyme-mediated DNA religation by 4'-(9-acridinylamino)methanesulfon-m-anisidide. , 1990, Biochemistry.

[39]  J. Holden,et al.  Human DNA topoisomerase II: evaluation of enzyme activity in normal and neoplastic tissues. , 1990, Biochemistry.

[40]  Yamashita Yoshinori,et al.  Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. , 1990 .

[41]  T. Gootz,et al.  Inhibitory effects of quinolone antibacterial agents on eucaryotic topoisomerases and related test systems , 1990, Antimicrobial Agents and Chemotherapy.

[42]  C. Zimmer,et al.  Microbial DNA topoisomerases and their inhibition by antibiotics , 1990, Journal of basic microbiology.

[43]  L. Liu,et al.  DNA topoisomerases as anticancer drug targets. , 1990, Advances in pharmacology.

[44]  D. Hooper,et al.  Fluoroquinolone antimicrobial agents. , 1991, Clinical microbiology reviews.

[45]  T. Hsieh,et al.  Nuclease protection by Drosophila DNA topoisomerase II. Enzyme/DNA contacts at the strong topoisomerase II cleavage sites. , 1989, The Journal of biological chemistry.

[46]  T. Gootz,et al.  Biochemical characteristics and physiological significance of major DNA topoisomerases , 1989, Antimicrobial Agents and Chemotherapy.

[47]  M. E. Cullen,et al.  Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance. , 1989, The American journal of medicine.

[48]  L. Dillehay,et al.  DNA topoisomerases and models of sister-chromatid exchange. , 1989, Mutation research.

[49]  L. Zwelling,et al.  Characterization of an amsacrine-resistant line of human leukemia cells. Evidence for a drug-resistant form of topoisomerase II. , 1989, The Journal of biological chemistry.

[50]  T. Gootz,et al.  Use of in vitro topoisomerase II assays for studying quinolone antibacterial agents , 1989, Antimicrobial Agents and Chemotherapy.

[51]  T. Une,et al.  Inhibitory effects of quinolones on DNA gyrase of Escherichia coli and topoisomerase II of fetal calf thymus , 1989, Antimicrobial Agents and Chemotherapy.

[52]  A. Jacquemin-Sablon,et al.  Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. , 1989, Cancer research.

[53]  L. Liu,et al.  Topoisomerase II-mediated DNA cleavage by amonafide and its structural analogs. , 1989, Molecular pharmacology.

[54]  N. Osheroff,et al.  Strand specificity of the topoisomerase II mediated double-stranded DNA cleavage reaction. , 1989, Biochemistry.

[55]  N. Osheroff,et al.  Double-stranded DNA cleavage/religation reaction of eukaryotic topoisomerase II: evidence for a nicked DNA intermediate. , 1989, Biochemistry.

[56]  N. Osheroff,et al.  Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide. , 1989, Biochemistry.

[57]  L. Liu,et al.  Evidence for the reversibility of cellular DNA lesion induced by mammalian topoisomerase II poisons. , 1989, The Journal of biological chemistry.

[58]  R. Hertzberg,et al.  On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. , 1989, Biochemistry.

[59]  W. Kohlbrenner,et al.  Mechanism of quinolone inhibition of DNA gyrase. Appearance of unique norfloxacin binding sites in enzyme-DNA complexes. , 1989, The Journal of biological chemistry.

[60]  J. Leatherwood,et al.  Bacteriophage T4 DNA topoisomerase is the target of antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) in T4-infected Escherichia coli. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[61]  E. Wyckoff,et al.  Structure of the Drosophila DNA topoisomerase II gene. Nucleotide sequence and homology among topoisomerases II. , 1989, Journal of molecular biology.

[62]  L. Liu,et al.  DNA topoisomerase poisons as antitumor drugs. , 1989, Annual review of biochemistry.

[63]  N. Osheroff.  Biochemical basis for the interactions of type I and type II topoisomerases with DNA. , 1989, Pharmacology & therapeutics.

[64]  G. Goldenberg,et al.  Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines. , 1989, Cancer research.

[65]  C. Robson,et al.  Nuclear topoisomerase II levels correlate with the sensitivity of mammalian cells to intercalating agents and epipodophyllotoxins. , 1988, The Journal of biological chemistry.

[66]  M. Muller,et al.  Single-strand DNA cleavages by eukaryotic topoisomerase II. , 1988, Biochemistry.

[67]  H. Aoyama,et al.  Effects of fleroxacin on HeLa cell functions and topoisomerase II. , 1988, The Journal of antimicrobial chemotherapy.

[68]  W. Ross,et al.  DNA binding by epipodophyllotoxins and N-acyl anthracyclines: implications for mechanism of topoisomerase II inhibition. , 1988, Molecular pharmacology.

[69]  F. Traganos,et al.  Resistance of human leukemic and normal lymphocytes to drug-induced DNA cleavage and low levels of DNA topoisomerase II. , 1988, Cancer research.

[70]  L. Liu,et al.  Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells. , 1988, Cancer research.

[71]  L. Liu,et al.  Illegitimate recombination mediated by calf thymus DNA topoisomerase II in vitro. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[72]  C. Paoletti,et al.  Pattern of recognition of DNA by mammalian DNA topoisomerase II. , 1988, Biochemical and biophysical research communications.

[73]  N. Osheroff.  Role of the divalent cation in topoisomerase II mediated reactions. , 1987, Biochemistry.

[74]  T. Uemura,et al.  DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe , 1987, Cell.

[75]  D. Sullivan,et al.  Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells. , 1987, Cancer research.

[76]  N. Osheroff,et al.  Calcium-promoted DNA cleavage by eukaryotic topoisomerase II: trapping the covalent enzyme-DNA complex in an active form. , 1987, Biochemistry.

[77]  D. S. Coffey,et al.  Growth-related elevations of DNA topoisomerase II levels found in Dunning R3327 rat prostatic adenocarcinomas. , 1987, Cancer research.

[78]  W. Earnshaw,et al.  Topoisomerase II: A specific marker for cell proliferation , 1986, The Journal of cell biology.

[79]  F. Grosse,et al.  Purification and characterization of DNA topoisomerase II from calf thymus associated with polypeptides of 175 and 150 kDa. , 1986, European journal of biochemistry.

[80]  N. Osheroff.  Eukaryotic topoisomerase II. Characterization of enzyme turnover. , 1986, The Journal of biological chemistry.

[81]  F. Grosse,et al.  Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts , 1986, Antimicrobial Agents and Chemotherapy.

[82]  C. Larsen,et al.  In vivo stimulation by antitumor drugs of the topoisomerase II induced cleavage sites in c-myc protooncogene. , 1986, Biochemical and biophysical research communications.

[83]  T. Uemura,et al.  Mitotic spindle pulls but fails to separate chromosomes in type II DNA topoisomerase mutants: uncoordinated mitosis , 1986, The EMBO journal.

[84]  U. K. Laemmli,et al.  Metaphase chromosome structure. Involvement of topoisomerase II. , 1986, Journal of molecular biology.

[85]  U. K. Laemmli,et al.  The organisation of chromatin loops: characterization of a scaffold attachment site , 1986, The EMBO journal.

[86]  K. Kohn,et al.  Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II. , 1986, Biochemistry.

[87]  K. Kohn,et al.  Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei. , 1985, Biochemistry.

[88]  K. Kohn,et al.  Effects of the DNA intercalators 4'-(9-acridinylamino)methanesulfon-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II mediated DNA strand cleavage and strand passage. , 1985, Biochemistry.

[89]  N. Osheroff,et al.  In situ localization of DNA topoisomerase II, a major polypeptide component of the Drosophila nuclear matrix fraction. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[90]  D. Botstein,et al.  DNA topoisomerase II is required at the time of mitosis in yeast , 1985, Cell.

[91]  W. Earnshaw,et al.  Topoisomerase II is a structural component of mitotic chromosome scaffolds , 1985, The Journal of cell biology.

[92]  W. Earnshaw,et al.  Localization of topoisomerase II in mitotic chromosomes , 1985, The Journal of cell biology.

[93]  T. Hsieh,et al.  Drosophila topoisomerase II double-strand DNA cleavage: analysis of DNA sequence homology at the cleavage site. , 1985, Nucleic acids research.

[94]  L. Liu,et al.  Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage. , 1984, Cancer research.

[95]  L. Liu,et al.  Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. , 1984, The Journal of biological chemistry.

[96]  L. Liu,et al.  Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. , 1984, Science.

[97]  T. Uemura,et al.  Isolation of type I and II DNA topoisomerase mutants from fission yeast: single and double mutants show different phenotypes in cell growth and chromatin organization. , 1984, The EMBO journal.

[98]  K. Kohn,et al.  Formation and rejoining of deoxyribonucleic acid double-strand breaks induced in isolated cell nuclei by antineoplastic intercalating agents. , 1984, Biochemistry.

[99]  R. Sternglanz,et al.  DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[100]  T. Goto,et al.  Yeast DNA topoisomerase II is encoded by a single-copy, essential gene , 1984, Cell.

[101]  L. Liu,et al.  Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[102]  L. Liu,et al.  Cleavage of DNA by mammalian DNA topoisomerase II. , 1983, The Journal of biological chemistry.

[103]  N. Osheroff,et al.  DNA topoisomerase II from Drosophila melanogaster. Relaxation of supercoiled DNA. , 1983, The Journal of biological chemistry.

[104]  M. Duguet,et al.  DNA topoisomerases from rat liver: physiological variations. , 1983, Nucleic acids research.

[105]  K. Kohn,et al.  Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin. , 1981, Biochemistry.

[106]  L. Liu,et al.  A homogeneous type II DNA topoisomerase from HeLa cell nuclei. , 1981, The Journal of biological chemistry.

[107]  M. Waring,et al.  Interaction of the antitumor drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines with nucleic acids. , 1981, Molecular pharmacology.

[108]  M. Waring,et al.  DNA modification and cancer. , 1981, Annual review of biochemistry.

[109]  D. Brutlag,et al.  ATP-dependent DNA topoisomerase from D. melanogaster reversibly catenates duplex DNA rings , 1980, Cell.

[110]  N. Cozzarelli,et al.  Escherichia coli Mutants Thermosensitive for Deoxyribonucleic Acid Gyrase Subunit A: Effects on Deoxyribonucleic Acid Replication, Transcription, and Bacteriophage Growth , 1979, Journal of bacteriology.

[111]  K. Kohn,et al.  Qualitative and quantitative aspects of intercalator-induced DNA strand breaks. , 1979, Biochimica et biophysica acta.

[112]  K W Kohn,et al.  Protein-associated DNA breaks in cells treated with adriamycin or ellipticine. , 1978, Biochimica et biophysica acta.

[113]  N. Cozzarelli,et al.  Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[114]  M. Gellert,et al.  Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. , 1977, Proceedings of the National Academy of Sciences of the United States of America.